Tech Company Financing Transactions
Aphea.Bio Funding Round
Innovation Industries, Bill & Melinda Gates Foundation and BNP Paribas Fortis participated in a $78.7 million Series C capital raise for Aphea.Bio. The financing round was announced by the company on 7/12/2023.
Transaction Overview
Company Name
Announced On
7/12/2023
Transaction Type
Venture Equity
Amount
$78,660,000
Round
Series C
Investors
Proceeds Purpose
This strategic investment aims to advance sustainable agriculture practices, reinforcing ECBF's commitment to the transition to an healthier and more resilient food system.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Technologiepark 21 Zwijnaarde
Ghent, 9052
BE
Ghent, 9052
BE
Phone
Undisclosed
Website
Email Address
Overview
Aphea.Bio is dedicated to food security and ensuring a safe and healthy food chain. We aim to provide novel science-based solutions to build the agriculture of the future: sustainable, reliable and profitable. Aphea.Bio is proud to be a member of the B Corp community committed to using business as a force for good.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Isabel Vercauteren
Chief Financial Officer
Geert Bossuyt
Chief Technical Officer
Steven Vandenabeele
Browse more venture capital transactions:
Prev: 7/12/2023: Inngest venture capital transaction
Next: 7/12/2023: Fairlyne venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs